Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics

4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics

US Patent 8299259 · Granted Oct 30, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of crosslinking glycosaminoglycans2023
Carbohydrate crosslinker2023
Carbohydrate crosslinker2023
Carbohydrate crosslinker2022
Method of crosslinking glycosaminoglycans2022
Cyclodextrin-grafted cross-linked hyaluronic acid complexed with active drug sub2021
Grafting of cyclodextrin by amide bonds to an ether cross-linked hyaluronic acid2020
Method for synthesizing enantiomerically pure N-(pyridin-4-yl)-2-hydroxy-alkylam2019
Single step functionalization and cross-linking of hyaluronic acid2018
Enantiopure or enantioenriched BDDE and its use as crosslinking agent in the man2018
Method for the synthesis of 4-(heterocycloalkyl)-benzene-1,3,-diol compounds2017
Method of synthesising 4-piperidin-4-yl-benzene-1,3-diol and the salts of same a2017